This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics Scientific Forum
See You Next Year! 26-28 Feb, 2025
Westin Miyako KyotoKyoto, Japan



Azemidite is a company which focuses on the manufacture, sales of bulk phosphoramidites used in the production of oligonucleotide therapeutics. The company’s team has over 20 years experiences in R&D and manufacture of phosphoramidites and nucleosides. The production workshop has been put into running with an annual output of 10 tons of phosphoramidites, and other seven production workshops have been reserved with a comprehensive production capacity of nearly 100 tons. The products cover the whole series of phosphoramidites, and the core raw materials are all produced in house. The stable bulk production process and high purity phosphoramidites meet the needs of the development and manufacturing requirements in the pharmaceutical industry. Having the ability to strictly control the critical impurities and non-critical impurities of each of phosphoramidites. Based on the principles of ISO 9001and ICH Q7, established a complete quality management system to meet the development and manufacturing requirements of various customers.

Azemidite is striving to be a major service provider and supplier of Phosphoramidites global.